Platelets are cells that help your blood clot, and it was so unusual to see blood clots combined with low platelet levels, ...

During the COVID pandemic, many of us have received multiple mRNA vaccines. New work by researchers at the VIB-UGent Center for Inflammation Research, Ghent University, and University Hospital Ghent, ...

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...

Experiments with mice that received repeated mRNA vaccination showed evidence of neutralizing antibody–producing cells in the ...

Moderna is already riding high on the strength of its mRNA-based COVID-19 vaccine, but the broader potential of its technology has been shown in a new AstraZeneca-partnered candidate for heart ...

One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

AstraZeneca and its biologics research arm MedImmune have signed a five-year strategic research collaboration with Ethris, an mRNA-based therapeutics company specialising in pulmonary disease.

Approvals for this and other vaccines, including shots developed by Moderna (another mRNA vaccine) and Oxford/AstraZeneca (a viral vector vaccine), followed elsewhere soon afterwards. Previously ...